As of Jun 18
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Cumberland Pharmaceuticals Inc have a median target of 9.25, with a high estimate of 9.25 and a low estimate of 9.25. The median estimate represents a +54.17% increase from the last price of 6.00.
The current consensus among 1 polled investment analysts is to Buy stock in Cumberland Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.